Global Nanoparticle Drug Delivery Systems Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Nanoparticle Drug Delivery Systems Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.

In this report, we only study liposomal/lipid nanoparticle drug delivery system.



LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).

In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.

According to our (Global Info Research) latest study, the global Nanoparticle Drug Delivery Systems market size was valued at US$ 5164 million in 2023 and is forecast to a readjusted size of USD 9845 million by 2030 with a CAGR of 9.8% during review period.

Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.

Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.

In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.

This report is a detailed and comprehensive analysis for global Nanoparticle Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Nanoparticle Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2019-2030

Global Nanoparticle Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Nanoparticle Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Nanoparticle Drug Delivery Systems market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Nanoparticle Drug Delivery Systems

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Nanoparticle Drug Delivery Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Nanoparticle Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Nanoparticle Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs

Market segment by Application
Hospital
Retail Pharmacy
Other

Market segment by players, this report covers
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Nanoparticle Drug Delivery Systems product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Nanoparticle Drug Delivery Systems, with revenue, gross margin, and global market share of Nanoparticle Drug Delivery Systems from 2019 to 2024.

Chapter 3, the Nanoparticle Drug Delivery Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nanoparticle Drug Delivery Systems market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Nanoparticle Drug Delivery Systems.

Chapter 13, to describe Nanoparticle Drug Delivery Systems research findings and conclusion.